REGISTERED NUMBER: 12150740 (England and Wales)

GHEZEL MEDICAL LTD

Unaudited Financial Statements for the Year Ended 31st December 2024

Page

Company Information

1

Abridged Balance Sheet

2

to

3

Notes to the Financial Statements

4

to

6

DIRECTOR:

Dr S Ghezel

REGISTERED OFFICE:

C/O TG Associates, 7 Jardine House

Harrovian Business Village

Bessborough Road

Harrow

HA1 3EX

REGISTERED NUMBER:

12150740 (England and Wales)

ACCOUNTANTS:

TG Associates Limited

Chartered Accountants

7 Jardine House

Harrovian Business Village

Bessborough Road

Harrow

Middlesex

HA1 3EX

FIXED ASSETS

Tangible assets

4

358,909

407,537

Investments

5

128,518

107,543

487,427

515,080

CURRENT ASSETS

Debtors

199,052

133,330

Cash at bank

4,753

1,634

203,805

134,964

CREDITORS

Amounts falling due within one year

(230,929

)

(84,384

)

NET CURRENT (LIABILITIES)/ASSETS

(27,124

)

50,580

TOTAL ASSETS LESS CURRENT LIABILITIES

460,303

565,660

CREDITORS

Amounts falling due after more than one year

6

(226,897

)

(309,762

)

NET ASSETS

233,406

255,898

CAPITAL AND RESERVES

Called up share capital

100

100

Retained earnings

233,306

255,798

SHAREHOLDERS' FUNDS

233,406

255,898

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st December 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Balance Sheet for the year ended 31st December 2024 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 9th December 2025 and were signed by:

Dr S Ghezel - Director

1.	STATUTORY INFORMATION

Ghezel Medical Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

In view of the directors, the value of freehold property has gone up and therefore in order to give a fair view of the results, no amortisation has been provided on freehold property and it is shown in the accounts at the original cost

Investments in subsidiaries

Investments in subsidiary undertakings are recognised at cost.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

4.	TANGIBLE FIXED ASSETS

Totals

£

COST

At 1st January 2024

429,213

Additions

22,577

Disposals

(86,705

)

At 31st December 2024

365,085

DEPRECIATION

At 1st January 2024

21,676

Charge for year

6,176

Eliminated on disposal

(21,676

)

At 31st December 2024

6,176

NET BOOK VALUE

At 31st December 2024

358,909

At 31st December 2023

407,537

5.	FIXED ASSET INVESTMENTS

Information on investments other than loans is as follows:

Totals

£

COST

At 1st January 2024

and 31st December 2024

150

NET BOOK VALUE

At 31st December 2024

150

At 31st December 2023

150

Investments (neither listed nor unlisted) were as follows:

31.12.24

31.12.23

£

£

Other Investments bfwd

107,393

67,650

Other Investment additions

20,975

39,743

128,368

107,393

6.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN FIVE YEARS

31.12.24

31.12.23

£

£

Repayable by instalments

Bank loans more 5 yr by instal

226,897

309,762

7.	SECURED DEBTS

The following secured debts are included within creditors:

31.12.24

31.12.23

£

£

Bank loans

309,897

392,031

Bank loans are secured by way of fixed and floating charge over the company assets including personal guarantee given by the director.

8.	DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31st December 2024 and 31st December 2023:

31.12.24

31.12.23

£

£

Dr S Ghezel

Balance outstanding at start of year

-

-

Amounts advanced

83,131

-

Amounts repaid

-

-

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

83,131

-

The company received interest amounting to £1,829 at the official rate of interest on the directors loan account